Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02511925
Other study ID # 2013IC004B
Secondary ID
Status Completed
Phase N/A
First received November 26, 2013
Last updated July 27, 2015
Start date November 2013
Est. completion date July 2014

Study information

Verified date July 2015
Source Royal Brompton & Harefield NHS Foundation Trust
Contact n/a
Is FDA regulated No
Health authority United Kingdom: National Health Service
Study type Observational

Clinical Trial Summary

If patients acquire a new infection whilst in hospital this can cause significant morbidity, prolonged hospitalisation and even death. Indeed, there is much public concern about infections such as MRSA. Patients who require intensive care are probably at the greatest risk.

Appropriate hand hygiene by healthcare workers can reduce infection rates and is a key goal of many patient safety initiatives. Worldwide, hand hygiene compliance has been estimated at only 38.7% despite the intervention being simple and cheap. Reasons for poor compliance include lack of time, skin irritation, lack of facilities, intensity of workload and forgetfulness. Furthermore, since cross infection may not be apparent for some days, staff may not associate their (lack of) actions with having caused harm.

Measuring compliance levels enables staff to understand whether they could improve. Direct observation of staff is labour intensive and is not continuous or universal. We will monitor hand hygiene compliance with a newly developed electronic system (MedSense, General Sensing Inc.). We will use the data to provide feedback to the staff in several ways. We hypothesise that comprehensive personalised feedback will reduce healthcare associated infections. We will undertake the study in three intensive care units.


Description:

All patients admitted to three intensive care units will be monitored for healthcare associated infections. In parallel the units will be cluster randomised to implement the electronic compliance monitoring in three different ways:

- Unit level feed back every week of current compliance for each of three staff groupings (doctors, nurses, allied health professionals)

- Personalised feedback in the form of an email at the end of a shift stating an individuals performance relative to the average for their professional grouping.

- Real time feedback in the form of a badge worn by the healthcare worker that vibrates when the system thinks they have missed or are about to miss an opportunity for hand hygiene.

All healthcare workers will receive the level of feedback defined in the randomisation for the duration of the three intervention periods. The units will cross-over with an interventing two week wash out period.

All personal feedback will be confidential and private to the individual.


Recruitment information / eligibility

Status Completed
Enrollment 1065
Est. completion date July 2014
Est. primary completion date July 2014
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- All patients admitted to the intensive care units

- All healthcare workers caring for the patients on the intensive care units.

Exclusion Criteria:

- Healthcare workers with skin sensitivity to both alcohol hand rub and soap

Study Design

Observational Model: Case-Crossover, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Other:
Weekly poster of unit performance
Weekly feedback is provided to the ICU about current levels of hand hygiene compliance amongst doctors, nurses, and allied healthcare professionals
Daily email of personal feedback
Healthcare workers receive private and personal feedback via email regarding their individual performance benchmarked against the average performance for their professional grouping.
Active reminder from badge
The badge the healthcare worker is wearing vibrates if opportunities to perform hand hygiene are missed

Locations

Country Name City State
United Kingdom Royal Brompton and Harefield NHS Foundation Trust London

Sponsors (1)

Lead Sponsor Collaborator
Royal Brompton & Harefield NHS Foundation Trust

Country where clinical trial is conducted

United Kingdom, 

References & Publications (1)

Cheng VC, Tai JW, Ho SK, Chan JF, Hung KN, Ho PL, Yuen KY. Introduction of an electronic monitoring system for monitoring compliance with Moments 1 and 4 of the WHO "My 5 Moments for Hand Hygiene" methodology. BMC Infect Dis. 2011 May 26;11:151. doi: 10.1186/1471-2334-11-151. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Staff attitudes to electronic compliance monitoring Quantitative and qualitative analysis of questionnaire data 0 and 24 weeks No
Other Surrogate measures of hand hygiene compliance Alcohol hand rub usage, Soap usage and visual compliance monitoring 24 weeks No
Primary Composite health care infection rate One of the following three:
Bacteriological proven infection at a normally sterile site. The sterile sites vein considered are a prior defined as blood, broncho-alveolar lavage, urine sampled from a catheter, chest drain fluid, and surgical wounds. Blood cultures that grow normal skin commensals will be included Endotracheal secretions that culture organisms other than normal upper respiratory tract flora Clostridium difficult related diarrhoea
Until the end of the second calendar day following ICU discharge No
Secondary Incidence of central line associated blood stream infections CDC definition Until the end of the second calendar day following ICU discharge No
Secondary Incidence of catheter associated urinary tract infections CDC definition Until the end of the second calendar day following ICU discharge No
Secondary Incidence of ventilator associated pneumonia CDC definition Until the end of the second calendar day following ICU discharge No
Secondary Incidence of surgical site infection Public Health England definition Until the end of the second calendar day following ICU discharge No
Secondary Incidence of clostridium difficult diarrhoea Public Health England definition Until the end of the second calendar day following ICU discharge No
Secondary Incidence of acquisition of new methicilllin resistant staphylococcus aureus Until the end of the second calendar day following ICU discharge No
Secondary Incidence of secondary blood stream infections CDC definition Until the end of the second calendar day following ICU discharge No
Secondary Incidence of antibiotic resistance infections Pre-defined as Acinetobacter baumanii, Pseudomonas aeroginosa (Extended-Spectrum Beta Lacatamase [ESBL] producing), Klebsiella penumoniae (ESBL producing), Escherichia coli (ESBL producing), Stenotrophomonas maltophilia, Serratia marcescens, Clostridium difficile, or MRSA. Until the end of the second calendar day following ICU discharge No
Secondary Adverse event rate 24 weeks Yes
See also
  Status Clinical Trial Phase
Completed NCT05547646 - The Prevalence of Healthcare-associated Infection in Medical Intensive Care Units in Tunisia
Completed NCT00195351 - Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection Phase 4
Completed NCT00079885 - Study Evaluating Tigecycline vs Levofloxacin in Hospitalized With Community-Acquired Pneumonia Phase 3
Completed NCT00156377 - Prophylaxis With Intranasal Mupirocin for Prevention of S. Aureus Infections Phase 4
Completed NCT00081744 - Study Comparing Tigecycline to Imipenem/Cilastatin in Complicated Intra-Abdominal Infections in Hospitalized Subjects Phase 3
Completed NCT00233376 - Computerized Decision Support System for Antibiotic Treatment Phase 3
Completed NCT00965848 - A Safety and Efficacy Study of Doripenem in Participants With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Urinary Tract Infections Phase 4
Completed NCT01640925 - Trial of 2% Chlorhexidine Bathing on Nosocomial Infections in the Surgical Intensive Care Unit N/A
Completed NCT00081575 - Study Comparing Tigecycline vs. Levofloxacin in Subjects Hospitalized With Community-Acquired Pneumonia Phase 3
Recruiting NCT04900298 - Reducing Intraoperative ESKAPE Transmission Through Use of a Personal Hand Hygiene System N/A
Enrolling by invitation NCT03910920 - Cross Transmissions of Pseudomonas Aeruginosa Between Children From a Same Cystic Fibrosis Center.
Not yet recruiting NCT01245829 - A Randomized Trial Comparing Matt and Antimicrobial Cellomed Laminates N/A
Recruiting NCT06194903 - Randomized Pilot Study Evaluating Isopropyl Alcohol and UVC Rays in Disinfection of Cell Phones N/A
Active, not recruiting NCT00197847 - Infection Surveillance in Intensive Care Patients N/A
Completed NCT01114347 - Prevention of Nosocomial E. Coli Infections After Placement of an Indwelling Catheter During Pelvic Surgery: an Evaluation of Cranberry Gel Capsules Phase 2
Recruiting NCT05326945 - Use of Disposable Cuff Cover to Prevent Carriage of Pathogen Microorganisms Originated by Cuffs N/A
Completed NCT03025672 - Evaluation of the Cost of a Nosocomial Infection With Clostridium Difficile N/A
Recruiting NCT00645723 - Intravenous Colistin Versus Intravenous Colistin Plus Nebulized Colistin in VAP Due MDR Acinetobacter Baumannii Phase 3
Recruiting NCT06392568 - Epidemiological Features of Emergent Highly Resistant Bacteria in Tunisian Intensive Care Units